Tredje Ap Fonden Johnson & Johnson Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Johnson & Johnson stock. As of the latest transaction made, Tredje Ap Fonden holds 113,377 shares of JNJ stock, worth $17.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

113,377

Previous 152,622 25.71%

Holding current value

$17.6 Million

Previous $22.3 Million 17.64%

% of portfolio

0.17%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$145.48 - $167.38 $5.71 Million - $6.57 Million	-39,245 Reduced 25.71%	113,377 $18.4 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $3.31 Million - $3.61 Million	-22,900 Reduced 13.05%	152,622 $22.3 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $9.88 Million - $10.4 Million	-63,629 Reduced 26.61%	175,522 $27.8 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $23 Million - $25.1 Million	-157,760 Reduced 39.75%	239,151 $37.5 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $5.82 Million - $6.52 Million	-37,381 Reduced 8.61%	396,911 $61.8 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $1.36 Million - $1.47 Million	-8,823 Reduced 1.99%	434,292 $71.9 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $644,983 - $769,710	4,270 Added 0.97%	443,115 $68.7 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $9.4 Million - $10.5 Million	58,646 Added 15.43%	438,845 $77.5 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $14.6 Million - $16.2 Million	90,190 Added 31.1%	380,199 $62.1 Million
Q1 2022 May 09, 2022	BUY	$158.14 - $179.59 $8.7 Million - $9.88 Million	55,000 Added 23.4%	290,009 $51.4 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $4.15 Million - $4.6 Million	26,601 Added 12.76%	235,009 $40.2 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $1.78 Million - $1.97 Million	11,000 Added 5.57%	208,408 $33.7 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $12.8 Million - $13.7 Million	80,000 Added 68.14%	197,408 $32.5 Million
Q1 2021 May 10, 2021	SELL	$153.07 - $170.48 $1.22 Million - $1.36 Million	-8,000 Reduced 6.38%	117,408 $19.3 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $6.17 Million - $7.08 Million	45,000 Added 55.96%	125,408 $19.7 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $8.42 Million - $9.23 Million	-60,000 Reduced 42.73%	80,408 $12 Million
Q2 2020 Aug 11, 2020	SELL	$128.81 - $155.51 $16 Million - $19.3 Million	-124,000 Reduced 46.9%	140,408 $19.7 Million
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $3.65 Million - $5.06 Million	32,877 Added 14.2%	264,408 $33.3 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $3.24 Million - $3.72 Million	-25,376 Reduced 9.88%	231,531 $33.8 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $393,164 - $440,207	3,097 Added 1.22%	256,907 $33.2 Million
Q2 2019 Aug 09, 2019	BUY	$131.15 - $144.24 $120,395 - $132,412	918 Added 0.36%	253,810 $35.4 Million
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $893,617 - $993,627	7,108 Added 2.89%	252,892 $35.4 Million
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $5.09 Million - $6.13 Million	-41,467 Reduced 14.44%	245,784 $31.7 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $8.11 Million - $9.53 Million	-66,680 Reduced 18.84%	287,251 $39.7 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $1.26 Million - $1.39 Million	10,517 Added 3.06%	353,931 $42.9 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $982,785 - $1.16 Million	-7,856 Reduced 2.24%	343,414 $44 Million
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $3.92 Million - $4.29 Million	-29,880 Reduced 7.84%	351,270 $49.1 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $49.3 Million - $51.6 Million	381,150	381,150 $49.6 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account